TP53 and neoplasm: 94.8% of patients showed at least one change detected in their ctDNAMedian maximum somatic allele frequency was 6.47% (0.1–34.8%)Higher tumor mutation burden: patients with mutations in LRP1B, TP53, or ERBB family genes had significantly higher tumor mutation burden